CLDX logo

Celldex Therapeutics, Inc. (CLDX) CAPEX

Annual CAPEX:

$1.92M+$101.00K(+5.56%)
December 31, 2024

Summary

  • As of today, CLDX annual capital expenditures is $1.92 million, with the most recent change of +$101.00 thousand (+5.56%) on December 31, 2024.
  • During the last 3 years, CLDX annual CAPEX has risen by +$670.00 thousand (+53.64%).
  • CLDX annual CAPEX is now -79.42% below its all-time high of $9.32 million, reached on December 31, 2006.

Performance

CLDX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXcash flow metrics

Quarterly CAPEX:

$728.00K+$463.00K(+174.72%)
June 30, 2025

Summary

  • As of today, CLDX quarterly capital expenditures is $728.00 thousand, with the most recent change of +$463.00 thousand (+174.72%) on June 30, 2025.
  • Over the past year, CLDX quarterly CAPEX has increased by +$454.00 thousand (+165.69%).
  • CLDX quarterly CAPEX is now -85.15% below its all-time high of $4.90 million, reached on December 31, 2007.

Performance

CLDX Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXcash flow metrics

TTM CAPEX:

$2.29M+$454.00K(+24.67%)
June 30, 2025

Summary

  • As of today, CLDX TTM capital expenditures is $2.29 million, with the most recent change of +$454.00 thousand (+24.67%) on June 30, 2025.
  • Over the past year, CLDX TTM CAPEX has increased by +$853.00 thousand (+59.20%).
  • CLDX TTM CAPEX is now -75.40% below its all-time high of $9.32 million, reached on December 31, 2006.

Performance

CLDX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXcash flow metrics

CLDX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+5.6%+165.7%+59.2%
3Y3 Years+53.6%+8.2%+28.4%
5Y5 Years+162.5%-20.0%+62.7%

CLDX CAPEX Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+53.6%-3.7%+363.7%at high+65.4%
5Y5-Yearat high+162.5%-3.7%+409.1%at high+105.4%
All-TimeAll-Time-79.4%+813.4%-85.2%>+9999.0%-75.4%+2979.2%

CLDX CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$728.00K(+174.7%)
$2.29M(+24.7%)
Mar 2025
-
$265.00K(-64.9%)
$1.84M(-4.1%)
Dec 2024
$1.92M(+5.6%)
$756.00K(+38.7%)
$1.92M(+4.9%)
Sep 2024
-
$545.00K(+98.9%)
$1.83M(+26.9%)
Jun 2024
-
$274.00K(-20.3%)
$1.44M(-8.6%)
Mar 2024
-
$344.00K(-48.3%)
$1.58M(-13.3%)
Dec 2023
$1.82M(-0.5%)
$666.00K(+324.2%)
$1.82M(+31.1%)
Sep 2023
-
$157.00K(-61.7%)
$1.39M(-11.9%)
Jun 2023
-
$410.00K(-29.9%)
$1.57M(-14.3%)
Mar 2023
-
$585.00K(+148.9%)
$1.84M(+0.5%)
Dec 2022
$1.83M(+46.4%)
$235.00K(-31.9%)
$1.83M(-6.1%)
Sep 2022
-
$345.00K(-48.7%)
$1.95M(+9.0%)
Jun 2022
-
$673.00K(+17.0%)
$1.79M(+42.2%)
Mar 2022
-
$575.00K(+62.4%)
$1.26M(+0.6%)
Dec 2021
$1.25M(-19.5%)
$354.00K(+91.4%)
$1.25M(+9.4%)
Sep 2021
-
$185.00K(+29.4%)
$1.14M(+2.2%)
Jun 2021
-
$143.00K(-74.8%)
$1.12M(-40.7%)
Mar 2021
-
$567.00K(+129.6%)
$1.88M(+21.4%)
Dec 2020
$1.55M(+112.3%)
$247.00K(+54.4%)
$1.55M(+10.1%)
Sep 2020
-
$160.00K(-82.4%)
$1.41M(+1.3%)
Jun 2020
-
$910.00K(+287.2%)
$1.39M(+78.5%)
Mar 2020
-
$235.00K(+123.8%)
$780.00K(+6.7%)
Dec 2019
$731.00K(-10.1%)
$105.00K(-26.1%)
$731.00K(-7.2%)
Sep 2019
-
$142.00K(-52.3%)
$788.00K(+11.6%)
Jun 2019
-
$298.00K(+60.2%)
$706.00K(-4.6%)
Mar 2019
-
$186.00K(+14.8%)
$740.00K(-9.0%)
Dec 2018
$813.00K(-54.5%)
$162.00K(+170.0%)
$813.00K(-3.3%)
Sep 2018
-
$60.00K(-81.9%)
$841.00K(-20.9%)
Jun 2018
-
$332.00K(+28.2%)
$1.06M(-36.5%)
Mar 2018
-
$259.00K(+36.3%)
$1.67M(-6.4%)
Dec 2017
$1.79M(-35.0%)
$190.00K(-32.6%)
$1.79M(-20.0%)
Sep 2017
-
$282.00K(-70.1%)
$2.24M(-19.0%)
Jun 2017
-
$942.00K(+151.9%)
$2.76M(+6.8%)
Mar 2017
-
$374.00K(-41.4%)
$2.58M(-6.0%)
Dec 2016
$2.75M(-43.6%)
$638.00K(-20.8%)
$2.75M(+9.2%)
Sep 2016
-
$806.00K(+5.1%)
$2.52M(-18.0%)
Jun 2016
-
$767.00K(+42.0%)
$3.08M(-20.2%)
Mar 2016
-
$540.00K(+32.7%)
$3.85M(-20.9%)
Dec 2015
$4.88M(+152.8%)
$407.00K(-70.1%)
$4.88M(+5.3%)
Sep 2015
-
$1.36M(-12.0%)
$4.63M(+17.5%)
Jun 2015
-
$1.55M(-0.9%)
$3.94M(+19.7%)
Mar 2015
-
$1.56M(+857.7%)
$3.29M(+70.8%)
Dec 2014
$1.93M(-54.3%)
$163.00K(-75.7%)
$1.93M(-52.8%)
Sep 2014
-
$672.00K(-25.3%)
$4.08M(-7.1%)
Jun 2014
-
$899.00K(+361.0%)
$4.40M(+3.4%)
Mar 2014
-
$195.00K(-91.6%)
$4.25M(+0.8%)
Dec 2013
$4.22M(+1292.4%)
$2.32M(+135.6%)
$4.22M(+109.8%)
Sep 2013
-
$984.00K(+30.3%)
$2.01M(+83.2%)
Jun 2013
-
$755.00K(+366.0%)
$1.10M(+159.6%)
Mar 2013
-
$162.00K(+47.3%)
$423.00K(+39.6%)
Dec 2012
$303.00K(-40.5%)
$110.00K(+54.9%)
$303.00K(+1.3%)
Sep 2012
-
$71.00K(-11.3%)
$299.00K(-14.3%)
Jun 2012
-
$80.00K(+90.5%)
$349.00K(0.0%)
Mar 2012
-
$42.00K(-60.4%)
$349.00K(-31.4%)
Dec 2011
$509.00K(-75.8%)
$106.00K(-12.4%)
$509.00K(-39.5%)
Sep 2011
-
$121.00K(+51.2%)
$841.00K(-32.9%)
Jun 2011
-
$80.00K(-60.4%)
$1.25M(-34.7%)
Mar 2011
-
$202.00K(-53.9%)
$1.92M(-8.7%)
Dec 2010
$2.10M(+297.7%)
$438.00K(-17.8%)
$2.10M(+20.0%)
Sep 2010
-
$533.00K(-28.5%)
$1.75M(+31.4%)
Jun 2010
-
$745.00K(+94.0%)
$1.33M(+72.6%)
Mar 2010
-
$384.00K(+336.4%)
$771.70K(+46.2%)
Dec 2009
$528.00K(-59.5%)
$88.00K(-23.5%)
$528.00K(+13.1%)
Sep 2009
-
$115.00K(-37.7%)
$466.70K(-62.1%)
Jun 2009
-
$184.70K(+31.6%)
$1.23M(-13.9%)
Mar 2009
-
$140.30K(+425.5%)
$1.43M(+9.8%)
Dec 2008
$1.30M
$26.70K(-97.0%)
$1.30M(-78.9%)
Sep 2008
-
$881.00K(+129.1%)
$6.18M(+16.6%)
Jun 2008
-
$384.50K(+2976.0%)
$5.30M(+7.5%)
DateAnnualQuarterlyTTM
Mar 2008
-
$12.50K(-99.7%)
$4.93M(-0.9%)
Dec 2007
$4.98M(-46.6%)
$4.90M(>+9900.0%)
$4.98M(+29.3%)
Sep 2007
-
$1500.00(-88.8%)
$3.85M(-42.8%)
Jun 2007
-
$13.40K(-76.9%)
$6.72M(-22.7%)
Mar 2007
-
$58.00K(-98.5%)
$8.70M(-6.7%)
Dec 2006
$9.32M(+328.5%)
$3.77M(+31.2%)
$9.32M(+46.3%)
Sep 2006
-
$2.88M(+44.7%)
$6.37M(+58.0%)
Jun 2006
-
$1.99M(+190.5%)
$4.04M(+61.4%)
Mar 2006
-
$684.40K(-17.0%)
$2.50M(+14.9%)
Dec 2005
$2.18M(-40.4%)
$824.70K(+53.2%)
$2.18M(-36.8%)
Sep 2005
-
$538.30K(+18.8%)
$3.44M(-15.2%)
Jun 2005
-
$453.20K(+26.0%)
$4.06M(+7.9%)
Mar 2005
-
$359.70K(-82.8%)
$3.77M(+3.2%)
Dec 2004
$3.65M(+1638.0%)
$2.09M(+81.0%)
$3.65M(+120.2%)
Sep 2004
-
$1.16M(+638.2%)
$1.66M(+202.4%)
Jun 2004
-
$156.70K(-35.9%)
$548.40K(+10.8%)
Mar 2004
-
$244.30K(+143.1%)
$495.10K(+20.4%)
Dec 2003
$210.10K(-75.0%)
$100.50K(+114.3%)
$411.10K(-22.9%)
Sep 2003
-
$46.90K(-54.6%)
$533.50K(-17.0%)
Jun 2003
-
$103.40K(-35.5%)
$643.10K(-15.7%)
Mar 2003
-
$160.30K(-28.1%)
$763.20K(-9.2%)
Dec 2002
$840.60K(+8.4%)
$222.90K(+42.4%)
$840.60K(+4.2%)
Sep 2002
-
$156.50K(-30.0%)
$807.00K(-12.9%)
Jun 2002
-
$223.50K(-6.0%)
$926.10K(+0.3%)
Mar 2002
-
$237.70K(+25.6%)
$923.50K(+19.1%)
Dec 2001
$775.40K(+68.9%)
$189.30K(-31.3%)
$775.40K(+12.3%)
Sep 2001
-
$275.60K(+24.8%)
$690.30K(+28.5%)
Jun 2001
-
$220.90K(+146.5%)
$537.00K(+24.9%)
Mar 2001
-
$89.60K(-14.0%)
$430.10K(-6.3%)
Dec 2000
$459.20K(-55.5%)
$104.20K(-14.8%)
$459.20K(-0.8%)
Sep 2000
-
$122.30K(+7.3%)
$463.10K(+35.9%)
Jun 2000
-
$114.00K(-4.0%)
$340.80K(+4.8%)
Mar 2000
-
$118.70K(+9.8%)
$325.20K(-52.8%)
Dec 1999
$1.03M(+43.3%)
$108.10K(>+9900.0%)
$688.50K(-5.2%)
Sep 1999
-
$0.00(-100.0%)
$726.00K(-9.3%)
Jun 1999
-
$98.40K(-79.6%)
$800.70K(+6.9%)
Mar 1999
-
$482.00K(+231.0%)
$749.00K(+154.1%)
Dec 1998
$720.80K(+57.3%)
$145.60K(+94.9%)
$294.80K(+97.6%)
Sep 1998
-
$74.70K(+60.0%)
$149.20K(+100.3%)
Jun 1998
-
$46.70K(+68.0%)
$74.50K(-41.7%)
Mar 1998
-
$27.80K(>+9900.0%)
$127.80K(+27.8%)
Dec 1997
$458.10K(-28.7%)
$0.00(0.0%)
$100.00K(-85.7%)
Sep 1997
-
$0.00(-100.0%)
$700.00K(-30.0%)
Jun 1997
-
$100.00K(-83.3%)
$1.00M(-61.5%)
Dec 1996
$642.70K(-64.2%)
$600.00K(+100.0%)
$2.60M(+23.8%)
Sep 1996
-
$300.00K(-57.1%)
$2.10M(-16.0%)
Jun 1996
-
$700.00K(-30.0%)
$2.50M(+38.9%)
Mar 1996
-
$1.00M(+900.0%)
$1.80M(+125.0%)
Dec 1995
$1.79M(+41.9%)
$100.00K(-85.7%)
$800.00K(+14.3%)
Sep 1995
-
$700.00K(>+9900.0%)
$700.00K(-12.5%)
Dec 1994
$1.26M(+152.8%)
$0.00(-100.0%)
$800.00K(0.0%)
Sep 1994
-
$100.00K(-80.0%)
$800.00K(-11.1%)
Jun 1994
-
$500.00K(+150.0%)
$900.00K(+80.0%)
Mar 1994
-
$200.00K(>+9900.0%)
$500.00K(0.0%)
Dec 1993
$500.00K(0.0%)
$0.00(-100.0%)
$500.00K(0.0%)
Sep 1993
-
$200.00K(+100.0%)
$500.00K(+25.0%)
Jun 1993
-
$100.00K(-50.0%)
$400.00K(-33.3%)
Mar 1993
-
$200.00K(+100.0%)
$600.00K(-14.3%)
Dec 1992
$500.00K(+25.0%)
-
-
Oct 1992
-
$100.00K(-66.7%)
$700.00K(0.0%)
Jul 1992
-
$300.00K(+50.0%)
$700.00K(+75.0%)
Apr 1992
-
$200.00K(+100.0%)
$400.00K(+33.3%)
Apr 1992
$400.00K(0.0%)
-
-
Jan 1992
-
$100.00K(0.0%)
$300.00K(-25.0%)
Oct 1991
-
$100.00K(0.0%)
$400.00K(0.0%)
Apr 1991
$400.00K(-42.9%)
$100.00K(-50.0%)
$400.00K(+33.3%)
Jan 1991
-
$200.00K(>+9900.0%)
$300.00K(+200.0%)
Oct 1990
-
$0.00(-100.0%)
$100.00K(0.0%)
Jul 1990
-
$100.00K
$100.00K
Apr 1990
$700.00K
-
-

FAQ

  • What is Celldex Therapeutics, Inc. annual capital expenditures?
  • What is the all-time high annual CAPEX for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. annual CAPEX year-on-year change?
  • What is Celldex Therapeutics, Inc. quarterly capital expenditures?
  • What is the all-time high quarterly CAPEX for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. quarterly CAPEX year-on-year change?
  • What is Celldex Therapeutics, Inc. TTM capital expenditures?
  • What is the all-time high TTM CAPEX for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. TTM CAPEX year-on-year change?

What is Celldex Therapeutics, Inc. annual capital expenditures?

The current annual CAPEX of CLDX is $1.92M

What is the all-time high annual CAPEX for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high annual capital expenditures is $9.32M

What is Celldex Therapeutics, Inc. annual CAPEX year-on-year change?

Over the past year, CLDX annual capital expenditures has changed by +$101.00K (+5.56%)

What is Celldex Therapeutics, Inc. quarterly capital expenditures?

The current quarterly CAPEX of CLDX is $728.00K

What is the all-time high quarterly CAPEX for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high quarterly capital expenditures is $4.90M

What is Celldex Therapeutics, Inc. quarterly CAPEX year-on-year change?

Over the past year, CLDX quarterly capital expenditures has changed by +$454.00K (+165.69%)

What is Celldex Therapeutics, Inc. TTM capital expenditures?

The current TTM CAPEX of CLDX is $2.29M

What is the all-time high TTM CAPEX for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high TTM capital expenditures is $9.32M

What is Celldex Therapeutics, Inc. TTM CAPEX year-on-year change?

Over the past year, CLDX TTM capital expenditures has changed by +$853.00K (+59.20%)
On this page